Literature DB >> 11865703

[Inflammatory markers after laparoscopy versus laparotomy cholecystectomy].

M Schietroma1, M Rossi, F Fraioli, C Liakos, A Carloni, S Mattucci, F Carlei, M A Pistoia.   

Abstract

OBJECTIVE: The study is carried out to determine whether the level of IL-6 is altered and in what way after surgery as well as if such a change could be an indicator of increased morbidity after surgical treatment. MATERIALS OF THE STUDY: Chemiluminesence immunoeassay system was used in order to establish IL-6 level in blood samples of 71 patients that underwent abdominal surgery, 36 Laparoscopic Cholecystectomy (LC) and 35 Open Cholecystectomy (OC) at time 0 (before the operation), 1 h, 2 h, 3 h, 6 h, 24 h and 48 h after the operation.
RESULTS: Plasma IL-6 levels are significantly increased after OC; we observed 3 cases of post-operative infections, in which IL-6 returned to normal levels 6 days after surgery. Analogous variation to the IL-6 levels was noted for the C-reactive protein levels. DISCUSSION: Laparoscopic cholecystectomy, a so called mini-invasive surgical procedure, is associated to a small increase of IL-6 serum levels and provides better post-operative conditions to the patients by reducing surgical stress and the infectious complications correlated to the surgical procedure.
CONCLUSIONS: During OC there is a significant higher elevation of IL-6 serum levels than after laparoscopic cholecystectomy. Variation of C-reactive protein serum levels after surgery is analogous to variation of IL-6 levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11865703

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  Composite Inflammatory Indicators as Early Predictor of Intra-abdominal Infections after General Surgery.

Authors:  Jiakun Song; Yurong Lu
Journal:  J Inflamm Res       Date:  2021-12-21

2.  Postoperative benefits of dexmedetomidine combined with flurbiprofen axetil after thyroid surgery.

Authors:  Xing-Dui Ma; Bei-Ping Li; De-Ling Wang; Wen-Sheng Yang
Journal:  Exp Ther Med       Date:  2017-07-04       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.